Christina Larkin
2017
In 2017, Christina Larkin earned a total compensation of $1.2M as Chief Operating Officer at Spero Therapeutics, a 200% increase compared to previous year.
Compensation breakdown
| Bonus | $98,325 |
|---|---|
| Option Awards | $796,800 |
| Salary | $330,669 |
| Other | $734 |
| Total | $1,226,528 |
Larkin received $796.8K in option awards, accounting for 65% of the total pay in 2017.
Larkin also received $98.3K in bonus, $330.7K in salary and $734 in other compensation.
Rankings
In 2017, Christina Larkin's compensation ranked 7,996th out of 14,666 executives tracked by ExecPay. In other words, Larkin earned more than 45.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,996 out of 14,666 | 46th |
Division Manufacturing | 3,001 out of 5,768 | 48th |
Major group Chemicals And Allied Products | 981 out of 2,074 | 53rd |
Industry group Drugs | 766 out of 1,730 | 56th |
Industry Pharmaceutical Preparations | 603 out of 1,329 | 55th |
Source: SEC filing on April 27, 2018.
Larkin's colleagues
We found three more compensation records of executives who worked with Christina Larkin at Spero Therapeutics in 2017.